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Methemoglobinemia, a disorder characterized by the presence of high methemoglobin levels in the blood, can occur in congenital and acquired forms. 
Methemoglobin is an oxidized form of hemoglobin, which has an 
increased affinity of oxygen and reduced ability to release oxygen 
to tissues. When methemoglobin concentration is elevated in 
red blood cells (RBC), tissue hypoxia may occur. This disorder 
may present with several symptoms such as cyanosis, dyspnea, 
and headache. Individuals with congenital methemoglobinemia 
will typically present with cyanosis in the neonatal period. In an 
arterial blood gas (ABG) analysis, these patients show a normal 
PaO2 despite cyanosis which gives clue to diagnosis.
Methemoglobinemia occurs rarely throughout the world. 
Cytochrome b5 reductase deficiency (type Ib5R) is also endemic 
in the Yakutsk people of Siberia [1]. The incidence of congenital 
methemoglobinemia in India is not known [1]. Few cases were 
reported in the newborn period, few unnoticed till old age. We present 
a patient who went unnoticed till the age of 4 years for her dusky bluish 
appearance. She consulted many physicians for this and they found her 
oxygen saturation in pulse oximetry was low. Multiple echocardiograms 
and chest X-rays were done and all reports turned normal and so she 
was referred to Ram Manohar Lohia Hospital, New Delhi.
CASE REPORT
A 4-year-old female child resident of Halwani presented with 
complaints of bluish discoloration of the tip of all fingers 
and toes, lips, and mouth since birth. The child was born to a 
non-consanguineously marriage couple and had no history of 
dyspnea, palpitation, seizures, limitation of physical activity, or 
developmental delay. The antenatal, natal, and postnatal periods 
were uneventful. The child achieved all developmental milestones 
in the appropriate age. The child is attending kindergarten and 
there are no issues in school. There was no history of any drug 
intake of recent procedure involving administration of anesthetic 
agents. The child had an elder sibling who is a 10-year-old boy 
who has no such complaints. The child’s paternal grandmother 
also had such bluish discoloration of fingers and perioral region 
and she had no other symptoms. The child had consulted local 
physicians for the same and multiple echocardiograms were done 
and were found to be normal.
On clinical examination, the heart rate was 102/min, respiratory 
rate was 26/min, temperature was normal, and pulses were normal. 
Central cyanosis was present. The child had no pallor, icterus, 
clubbing, lymphadenopathy, and pedal edema (Figs. 1 and 2). 
Systemic examination was also within normal limits.
Blood investigations showed hemoglobin 10 g/dL, total 
leukocyte count - 11,000 cells/mm3 with normal differential 
count, platelet count - 3.2×105/mm3, RBC - 4.92 million cells/
mm3, packed cell volume (PCV) - 34.1%, and mean corpuscular 
volume - 69.3 fl. Peripheral blood picture showed normocytic 
normochromic RBC, white blood cell, and platelets. Liver and 
kidney function tests were normal. SPO2 off oxygen was 88%, 
and with oxygen, at high flow mask, 6 lit/min was 90%. ABG 
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analysis without O2 showed pH - 7.49, PaCO2 - 25.8 mmHg, 
PaO2 - 82.3 mmHg, HCo3 - 19.8 mmol/L, and SO2% - 97.2% 
while ABG with O2 showed pH - 7.437, PaCO2 - 27.6 mmHg, 
PaO2 - 24.1 mmHg, HCo3 - 21.1 mmol/L, and SO2% - 99.5%. 
High-performance liquid chromatography (HPLC) was within 
normal limits. Heparin whole blood spectrometry showed 42.8% 
methemoglobin.
As the patient had cyanosis since birth with no drug 
exposure, a normal HPLC, and no developmental delay or 
central nervous system symptoms, a final diagnosis of Type 1 
congenital methemoglobinemia was made. Although she was 
not symptomatic, due to cosmetic concerns of parents, she was 
administered IV methylene blue at 2 mg/kg a single dose and 
was also given oral Vitamin C high dose 1000 mcg/day for a 
week. Cyanosis disappeared the following treatment.
DISCUSSION
Methemoglobin results from oxidation of ferrous iron (Fe2+) to 
ferric iron (Fe3+) within the heme moiety of hemoglobin [2]. 
Methemoglobin normally constitutes <1% of total hemoglobin. 
It cannot carry oxygen. Due to allosteric interactions within the 
methemoglobin molecule, the remaining binding sites show 
increased affinity to oxygen, which lead to a left shift in the 
oxygen dissociation curve [3]. These two phenomena lead to 
a reduction in the oxygen delivery to tissues and when severe 
enough leads to hypoxemia and lactic acidosis.
Increased methemoglobin content of RBCs occurs as a 
result of either acceleration of oxidation reaction or fall in a 
reduction reaction (redox imbalance) [4]. In patients of acquired 
methemoglobinemia, RBCs present with a huge exogenous oxidant 
load that overcomes the protective cellular reduction mechanisms. 
In cases of congenital methemoglobinemia, the enzyme cytochrome 
b5 reductase activity is diminished and there is a decrease in the 
rate of reduction of methemoglobin. The oxidant load in congenital 
methemoglobinemia is from endogenous sources [5].
A patient described in 1845, by Francois, had an enduring 
congenital cyanosis and there was an absence of any cardiac 
or pulmonary dysfunction [6]. Although this was the first case 
of congenital methemoglobinemia documented in literature, it 
was in 1932 that Hitzenberger found idiopathic cyanosis to be 
familial [7]. In the 1940s, Gibson [8,9] showed that there was 
a reduction in the ability of RBCs to reduce methemoglobin in 
such cases. In 1959, Scott and Griffith [10] identified the enzyme 
responsible for reducing methemoglobin in normal erythrocytes. 
They called this nicotinamide adenine dinucleotide (NADH)-
requiring enzyme diaphorase. Now, generally referred to as 
NADH-cytochrome b5 reductase, a functional deficiency in this 
enzyme is universally recognized as the underlying cause of 
congenital methemoglobinemia.
On extensive review of the English literature for cases 
diagnosed as congenital methemoglobinemia due to deficiency of 
cytochrome b5 reductase, we found 23 cases, 17 cases (~74%) of 
type I and 6 cases (27%) of type II. There is a male predominance, 
73% versus 26% in females. Almost half of the reported cases, 
12 cases (52%) were Indian, two Japanese, three English, two 
Arabic, one case was Spanish, and one case was Italian. The median 
age of presentation of type I methemoglobinemia was 31 years 
with cyanosis and shortness of breath being the most common 
sign and symptom. Six cases of type II methemoglobinemia were 
reported in English literature with the mean age of presentation 
at 6 years. Type II is always associated with neurological 
manifestations and mental retardation [11].
Methemoglobinemia is classified as congenital and 
acquired. Congenital methemoglobin is further classified as 
Type I: Cytochrome b5 reductase deficiency, demonstrable 
only in the erythrocytes, presents as uncomplicated, benign 
methemoglobinemia; Type II: Generalized cytochrome b5 
reductase deficiency, demonstrable in all tissues, is accompanied 
by severe, lethal, and progressive neurological disability, in 
addition to methemoglobinemia; Type III: Deficiency is limited 
to hematopoietic cells and resembles Type I clinically; and 
Type IV: methemoglobinemia clinically presents like the Type I 
disease and is associated with co factor FAD ( flavine adenine 
dinucleotide) and riboflavin deficiency. Acquired methemoglobin 
was classified according to the causes as occupational causes: 
Due to absorption of nitro and amino aromatic derivatives 
(nitrobenzene), nitrates, and aniline (usually absorbed through 
lungs) related to ICU hemodialysis: Household causes include 
Figure 1: Patient with congenital methemoglobinemia
Figure 2: Cyanosis in the fingers of the patient
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furniture and shoe polish containing marking ink, shoe dyes 
containing aniline, perfume, and flavoring essence and due to 
various drugs such as acetaminophen, benzocaine, dapsone, and 
disulfiram [12].
The clinical features of congenital methemoglobin were 
classified as Type 1: Methemoglobinemia (Cytochrome b5 reductase 
deficiency) causing bluish coloring of the skin (cyanosis) and 
Type 2: Methemoglobinemia (generalized cytochrome b5 reductase 
deficiency) causing developmental delay, failure to thrive, mental 
retardation, seizures, and hemoglobin M disease-causing bluish 
coloring of the skin (cyanosis) [13]. Acquired methemoglobinemia 
includes bluish coloring of skin, symptoms of anoxia including 
headache, dizziness, and tachycardia, shortness of breath, muscular 
cramps, and weakness in chronic occupational cases.
In cases of acute poisoning, vomiting, lethargy, loss of 
consciousness, circulatory failure, and death can occur. Individuals 
with congenital methemoglobinemia will typically present 
with cyanosis in the neonatal period. In managing a cyanotic 
patient, physicians will often obtain ABG analysis, in addition 
to monitoring pulse oximetry. Unfortunately, the patient with 
methemoglobinemia will often have normal values for both. In 
interpreting ABG data, the clinician must remember that the Pao2 
refers to the amount of dissolved oxygen in the blood and in no way 
reflects hemoglobin saturation and thus arterial oxygen content. 
Patients with life-threatening methemoglobinemia may have a 
normal Pao2 and a falsely elevated pulse oximetry reading [1].
Unlike a pulse oximeter, which measures light absorbance at two 
wavelengths (660 nm and 940 nm, corresponding to the absorption 
of oxyhemoglobin and deoxyhemoglobin, respectively), a 
cooximeter measures light absorbance at four different wavelengths. 
These wavelengths correspond to the absorption characteristics 
of deoxyhemoglobin, oxyhemoglobin, carboxyhemoglobin, and 
methemoglobin. As a consequence, cooximetry can distinguish 
between these four configurations while providing a more accurate 
measurement of oxygen saturation. Therefore, in patients who 
present with cyanosis of uncertain cause, cooximetry measurements 
are a valuable diagnostic tool [11].
Hemoglobin electrophoresis is also a very helpful adjunct in 
differentiating the different causes of congenital cyanosis. It will 
identify hemoglobin M, a hemoglobin variant that causes cyanosis 
as a result of structural changes in the α or β chains that stabilize 
the hemoglobin in the ferric state. These structural changes are 
attributable to amino acid substitutions at positions close to the 
heme groups in the hemoglobin molecule. Cyanosis is noticed at 
birth or within 4–6 months thereafter.
Once the diagnosis of methemoglobinemia has been made, there 
are various assays available to quantify NADH-cytochrome b5 
reductase activity [11]. Adult levels of enzyme function are attained 
by 2–3 months of age, and in the neonate, methemoglobin reductase 
levels are normally 60% of the normal adult value [2]. Methylene 
blue is the treatment of choice for severe methemoglobinemia. In 
the presence of NADH phosphate, methylene blue is converted to 
leucomethylene blue, which results in a non-enzymatic reduction 
of methemoglobin. Ascorbic acid directly reduces methemoglobin, 
but the rate of the reaction is too slow for it to be effective when 
used alone [7]. Finally, if the combination of ascorbic acid and 
methylene blue fails to reduce the methemoglobin level, then 
hyperbaric oxygen and exchange transfusions are alternative 
therapy [14]. Our patient was treated with IV methylene blue stat 
dose at 2 mg/kg/dose and oral Vitamin C 1000 mcg for 7 days. She 
improved and bluishness of fingers and perioral region disappeared.
CONCLUSION
Congenital methemoglobinemia is a very rarely reported disease. 
We discussed a case of Type 1 congenital methemoglobinemia 
who presented for bluish discoloration of fingers and lips without 
any other symptoms. Based on HPLC, blood spectrometry 
reports, and clinical findings, a final diagnosis of congenital 
methemoglobin was made.
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